Protection from Plasmodium berghei infection by priming and boosting T cells to a single class I-restricted epitope with recombinant carriers suitable for human use. (European journal of immunology, 1998)

(untitled) - Plebanski, M; Gilbert, S; Schneider, J; Hannan, C; Layton, G; Blanchard, T; Becker, M; Smith, G; Butcher, G; Sinden, R; Hill, A